南方医科大学学报 ›› 2015, Vol. 35 ›› Issue (05): 707-.

• • 上一篇    下一篇

葡萄胎病理相关新基因F10与绒癌细胞系JEG-3成瘤性的关系

苏晓华,庞战军,苏桂栋   

  • 出版日期:2015-05-20 发布日期:2015-05-20

Role of hydatidiform mole-related gene F10 in the tumorigenicity of choriocarcinoma cell
line JEG-3

  • Online:2015-05-20 Published:2015-05-20

摘要: 目的探讨葡萄胎病理相关新基因F10与绒癌细胞系JEG-3裸鼠皮下成瘤的关系。方法通过细胞转染技术及RNA干扰
技术,分别建立和筛选出F10 基因稳定过表达及沉默的绒癌细胞系JEG-3。取SPF级裸鼠(4~5周龄)30只,随机均分为JEG-3
F10过表达组、JEG-3 F10沉默组、JEG-3未处理组(n=10),分别接种F10基因过表达的JEG-3细胞、F10基因沉默的JEG-3细胞
和未处理的JEG-3细胞株5×107个于颈背部皮下。接种后每3~4 d称量裸鼠质量观察,记录肿瘤发生时间,观察皮下肿瘤的生长
情况。绘制在体肿瘤生长曲线,计算各组裸鼠的成瘤率。结果3组的成瘤率均为100%(10/10)。JEG-3 F10过表达组、JEG-3
F10 沉默组、JEG-3 未处理组的成瘤时间分别为6.2±0.78、7±2.49、6.3±0.67 d,组间比较无统计学差异(F=0.781,P=0.468)。
JEG-3 F10过表达组肿瘤的在体生长速度较JEG-3 F10沉默组、JEG-3未处理组增快,差异有统计学意义(P<0.05),JEG-3 F10未
处理组肿瘤的在体生长速度较JEG-3 F10沉默组快(P<0.05)。细胞接种5周后处死小鼠,取瘤组织称重,JEG-3 F10过表达组、
JEG-3 F10沉默组、JEG-3未处理组肿瘤重量分别为571.1±221.10 mg、136.2±66.25 mg、354.5±116.23 mg,组间比较存在统计学
差异(F=21.199,P=0.000)。结论F10基因与绒癌细胞系JEG-3的增殖调节有关,可增强JEG-3细胞系在裸鼠体内的致瘤性。

Abstract: Objective To explore the role of the hydatidiform mole-related gene F10 in the tumorigenicity of choriocarcinoma
cell lines JEG-3 in nude mice. Methods Choriocarcinoma JEG-3 cell lines with stable F10 gene over-expression and F10 gene
silencing were established using cell transfection and RNA interference techniques, respectively. Thirty SPF nude mice (4-5
weeks old) were equally randomized into F10 over-expression group, control group, and F10 gene-silenced group for
subcutaneous injection of 0.2 ml cell suspension (5×107 cells) of F10 gene over-expressing JEG-3 cells, non-treated JEG-3 cells,
and F10 gene-silenced JEG-3 cells, respectively. The mice were observed and weighed every 3-4 days, and the tumor formation
time was recorded to draw the tumor growth curve and calculate the tumor formation rate. Results The tumor formation rates
were 100% in all the 3 groups. No significant difference was found in the tumor formation time among the F10
over-expression, F10-silenced and control groups (6.2±0.78 vs 7±2.49 vs 6.3±0.67 days; F=0.781, P=0.468). A significantly greater
tumor growth rate was noted in the F10 over-expression group compared with the other two groups (P<0.05), and the growth
rate was significantly slower in F10-silenced group than in the control group (P<0.05). The subcutaneous tumor weight at 5
weeks after JEG-3 cell injection differed significantly among F10 over-expression, F10-silenced and control groups (571.1 ±
221.10 vs 136.2 ± 66.25 vs 354.5 ± 116.23 mg; F=21.199, P=0.000). Conclusion F10 gene plays a role in the regulation of
choriocarcinoma JEG-3 cell proliferation and might enhance its tumorigenicity in nude mice.